Vaccine Delivery Costing Study

In the News

Abstract submission for international workshop on infection prevention and control opens

Abstract submission for International Workshop on Infection Prevention and Control opens The National Institute for Medical Research (NIMR), Ministry of Health, Community Development, Gender, Elderly and Children and Infection Control …

The CED sums up year 2016/17 in latest message

2016/2017: Year of success despite challenges Ifakara Health Institute (IHI) Chief Executive Director (CED), Dr. Honorati Masanja, has penned a message which sums up the last (2016/2017) financial year. Read …

Recent Projects

Understanding and enhancing approaches to quality improvement in small and medium sized private facilities in sub-Saharan Africa

This is an evaluation study that IHI is conducting in collaboration with London school of hygiene and tropical medicine. The research takes place in the context of an innovative intervention …

Evaluation of Cepheid GeneXpert Omni combined with the Xpert MTB/RIF Ultra in Primary Health Care in Tanzania

GeneXpert Omni (Omni) is a new developed diagnostic tool with characteristic suitable for use in resource limited settings e.g. portability, battery powered. The GeneXpert Omni is considered the next generation …

As countries drive towards achieving high and equitable coverage of life-saving vaccines, the availability of sustainable, equitable, and predictable financing for vaccine delivery is essential. Over the last two decades, great strides have been made in expanding the coverage of routine and new vaccines, in part through better understanding the cost of delivering immunization services. However, gaps in cost evidence remain, such as the costs associated with different delivery strategies, the cost of scaling up, and the upstream drivers of immunization delivery costs. In addition, the data that do exist are often fragmented, of variable quality, and/or difficult to access and use by policymakers, program planners, and other global and country-level stakeholders. Consequently, historical funding levels, rather than cost evidence, are often used to plan and budget immunization programs.

Immunization delivery costing study aims to increase the visibility, availability, understanding, and use of evidence information on costing/budgeting of delivering immunization services. The IHI as country research partners to ThinkWell Institute, JSI and policymakers aims to build country capacity around generation, interpretation, and use of cost evidence to work towards sustainable and predictable financing for vaccine delivery.

This project focuses on vaccine delivery costs. For the purposes of this project, delivery costs are defined as the component of total immunization program cost, exclusive of vaccine costs. Delivery costs include the costs of vaccine administration (facility-based, outreach, or other delivery strategy), vaccine collection, distribution and storage and disposal, record-keeping and information systems, supervision, surveillance (AEFI and disease surveillance), training, social mobilization, and program management. Delivery costs include the costs of safe injection and waste disposal. Costs are expressed as financial costs (financial outlays) and valued as economic costs (taking into account the opportunity costs of health worker time).



No items found


No items found

Projects Location

© Ifakara Health Institute (IHI), 2016